IDEXX LABORATORIES INC (IDXX:NASDAQ)
$543.66 14.65 (2.7693%)
Analysed IDEXX LABORATORIES INC (IDXX:NASDAQ) News Sources
Is IDEXX’s Expanded Zoonosis Testing Menu Altering The Investment Case For IDEXX Laboratories (IDXX)?
17-09-2026
yahoo.com
IDEXX Stock Gains Following the Acquisition of CoVet
17-09-2026
yahoo.com
IDEXX Laboratories (IDXX) Could Be 29% Below Fair Value As Diagnostics Growth Stays In Focus
17-09-2026
yahoo.com
IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide
18-09-2026
yahoo.com
IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics
19-09-2026
yahoo.com
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
20-09-2026
marketbeat.com
Should You Continue to Hold IDXX Stock in Your Portfolio?
23-09-2026
yahoo.com
Companion Animal Diagnostic Market Forecasts Growth from $3.56B (2026) to $5.40B by 2031, Profiling IDEXX Laboratories & Zoetis
24-09-2026
yahoo.com
Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories
30-09-2026
yahoo.com
IDEXX Laboratories to Release 2026 Third Quarter Financial Results
01-10-2026
yahoo.com
What is the current price of IDEXX LABORATORIES INC (IDXX:NASDAQ)?
The current price of IDEXX LABORATORIES INC (IDXX:NASDAQ) is $543.66.
IDEXX LABORATORIES INC (IDXX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IDEXX LABORATORIES INC (IDXX:NASDAQ) since the previous trading day is $14.65.
IDEXX LABORATORIES INC (IDXX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IDEXX LABORATORIES INC (IDXX:NASDAQ) since the previous trading day is 2.7693%.
What is the most recent average sentiment score for IDEXX LABORATORIES INC (IDXX:NASDAQ)?
The most recent average sentiment score for IDEXX LABORATORIES INC (IDXX:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for IDEXX LABORATORIES INC (IDXX:NASDAQ)?
The most recent sentiment for IDEXX LABORATORIES INC (IDXX:NASDAQ) is .
SEC-8K** Filing Available For IDEXX LABORATORIES INC (IDXX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.